MeiraGTx
MGTX
£6.04
Share price
-1.94%
Change (1 day)
57.67%
Change (1 year)
Earnings for MeiraGTx (MGTX)
Earnings in 2025 (TTM): -£0.13 Billion
According to MeiraGTx's latest financial reports the company's current earnings are £34.5 Million. In 2024 the company made an earning of -£0.11 Billion a decrease over its 2023 earnings that were of -£53.01 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for MeiraGTx from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -£0.13 Billion | 19.16% |
| 2024 | -£0.11 Billion | 90.05% |
| 2023 | -£53.01 Million | -43.22% |
| 2022 | -£93.36 Million | 57.27% |
| 2021 | -£59.36 Million | 37.02% |
| 2020 | -£43.33 Million | 5.77% |
| 2019 | -£40.96 Million | -34.34% |
| 2018 | -£62.39 Million | 168.72% |
| 2017 | -£23.22 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -£87.74 Million | -24.05% | Jersey |
 Novavax NVAX | £0.38 B | -430.73% | 🇺🇸 USA |
 Organovo ONVO | -£1.87 Million | -98.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -£54.71 Million | -52.64% | 🇬🇧 UK |